AMH and polycystic ovary syndrome: Anti-Müllerian hormone (AMH) appears to better reflect OR [5], and is, therefore, increasingly utilized to detect diminished ovarian reserve (DOR) [6,7] and/or hyperstimulation risk in women with polycyctic ovarian syndrome (PCOS) [8].